Thank you again for submitting your manuscript for consideration by The EMBO Journal. We have now received the reports from three expert referees (copied below), who all consider your results on Saw1 in Rad1/Rad10 recruitment interesting and in principle suited for publication in our journal. Nevertheless, they do raise a number of concerns that will need to be satisfactorily addressed before eventual acceptance. I would therefore like to invite you to respond to the referees' comments and criticism in the form of a revised version of this manuscript. Should you be able to adequately address the main issues, we shall be happy to consider such a revision further for publication. I should however remind you that it is our policy to allow a single round of major revision only, and that it will therefore be important to diligently and comprehensively answer to all the specific points raised at this stage in the process. When preparing your letter of response to the referees' comments, please also bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html
We generally allow three months as standard revision time, and it is our policy that competing manuscripts published during this period will have no negative impact on our final assessment of your revised study. However, we request that you contact the editor as soon as possible upon publication of any related work, to discuss how to proceed. Should you foresee a problem in meeting this three-month deadline, please let us know in advance and we may be able to grant an extension.
Thank you for the opportunity to consider this work, and please do not hesitate to contact me in case you should have any additional question regarding this decision or the reports. I look forward to your revision.
_____ REFEREE REPORTS:
Referee #1 (Remarks to the Author):
Rad1/10 (and its human counterpart ERCC1-XPF) is a structure-specific endonulcease with roles in diverse DNA repair pathways including NER, ICL repair and HR. While impressive progress has been made toward understanding how this protein is recruited to NER and ICL repair pathways through interaction with Rad14/XPA and SLX4, respectively, we know less about interaction that target the protein to the ssDNA annealing (SSA) pathway of HR. The data in the manuscript by Li and colleagues shows that the Saw1 protein plays a key role in this regard. Using ChIP assays is shown that the recruitment of Rad1/10 to recombination intermediates critically depends on Saw1 (and Rad52 and MSH2) , and only partially on SLX4. Using biochemical approaches, the authors furthermore show that recombinant purified Saw1 binds to splayed arm structures and that interacts with Rad1/10 to facilitate the cleavage of flap structures. The use of Saw1 mutants that are defective in DNA or Rad1/10 binding support the interpretation of the results. This paper provides significant new insights into the function of SAW1 and the mechanisms by which Rad1/10 operates in SSA. Following the revisions suggested below, this manuscript deserves publication in the EMBO J.
Major points:
1. Fig. 5 . Some of the data in Figure 5A require clarification: The authors state that Saw1 copurified with Rad1/10 was used in the EMSA assays, yet increasing amount of Saw1 are used in the binding studies. This appears to be a contradiction. Was additional Saw1 added to the co-purified complex? 2. Fig. S9 . Saw1 appears to be present in significant excess over Rad1/10, even though if was purified through affinity with Rad1/10. Do the authors have an explanation for that -could SAW1 be present as a multimer? 3. Throughout: indicate amounts of protein and substrates used as concentrations rather than ng amounts.
4. The data presented here convincingly argue for a role of saw1 in mediating flap cleavage by Rad1/10 in SSA, but does saw1 also have a role in mediating the ICL repair function of saw1? A clarification of a potential role of saw1 in ICL repair would greatly strengthen the paper and could be easily addressed by testing the sensitivity of Saw1 mutants (including those with deficient DNA and Rad1/10 binding activity) to ICL forming agents such as mitomycin C or nitrogen mustards.
Minor points: p3 top: Ssl2/Rad3-mediated strand unwinding precedes incisions by Rad1/10 and Rad2, please adjust sentence. p3 4th line from bottom: There is now strong evidence that SLX4 has a role in targeting ERCC1-XPF to ICL repair substrates. The corresponding papers (Andersen et al; Fekari et al; Munoz et al; Svensden et al and Crossan et al Nat. Genet, 2011; Kim et al Nat Genet. 2011; Stoepker et al, Nat Genet 2011) should be cited here.
p4. 5th line: The paper by Motycka, 2004 shows a physical interaction between Rad52 and ERCC1-XPF, but not that this interaction is essential for targeting ERCC1-XPF to 3' non-homologous tails. Either correct sentence or provide another reference that directly shows a role for Rad52 in targeting ERCC1-XPF to those sites. p6./ Fig. S3 . Please also show recruitment data for WT-Rad1 in Figure S3 so that the reader can appreciate the effect of the nuclease-deficient mutant. In this study Lee and colleagues study the requirements for the recruitment of the Rad1-Rad10 nuclease to sites where 3' flaps need to be cleaved during single-strand annealing. They use a genetic system that they established in a previous study, where they discovered Saw1, a Rad1-Rad10-associated protein that is required for flap cleavage during SSA. In the current study they define a hierarchy of recruitment among proteins required for Rad1-Rad10-mediated flap cleavage. The authors show using ChIP that assembly of the tail removal complex requires binding of Rad52, then Msh2/3 and is completed by Saw1-dependent recruitment of Rad1/Rad10. The authors show that Saw1 is a structure-specific DNA binding protein and that it stimulates Rad1-Rad10 activity. The authors go on to define Saw1 mutant that cannot bind Rad1-Rad10 or that cannot bind to DNA, and they use these mutants to strengthen the notion that Saw1 binds to 3' flaps directly during SSA, and recruits Rad1-Rad10. This is a very elegant, very interesting and well-written paper that makes a major advance in our understanding of how Rad1-Rad10 works. The study clearly shows that Saw1 is central to recruitment of Rad1-Rad10. It is certainly deserving of publication in EMBO Journal.
Minor points: 1. rad1 should be in italics throughout; in places it's not italicized e.g. p6 2. In Figs 2C, D there's less Rad1-Rad10 recruited at the 3hr timepoints -is this difference reproducible and is it significant? Is the effect more pronounced at later time points? 3. In the discussion (p15) the authors state that Slx4 is a nuclease; it is not, it has no nuclease motifs. The data in support of Slx4 being a nuclease are weak, and the activity observed is almost certainly due to a contaminating nuclease. 4. Rad1-Rad10 interacts with Slx4. However, the authors showed previously that recruitment of Slx4 to 3' flaps during SSA does not require Saw1, even though in their current study they show that Rad1 recruitment requires Saw1. The authors must attempt to reconcile these data and provide possible explanations.
Referee #3 (Remarks to the Author):
The study by Li and colleagues provides an interesting biochemical and functional analysis of the Rad1-Rad10 associated role of Saw1. It builds up on their previous work on the identification of Saw1 as a novel cofactor of the Rad1-Rad10 endonuclease and their suggestion that Saw1 targets Rad1-Rad10 to Rad52-coated recombination intermediates. In the current manuscript the authors combine in vitro biochemical studies with cellular approaches to test this initial hypothesis by looking at the recruitment of Rad1-Rad10 at DNA ends during double-strand break repair and characterize the DNA binding properties of Saw1. Overall the data provide strong support to their initial model. The authors convincingly show that Saw1 promotes recruitment of Rad1-Rad10 at DNA ends during repair of DSBs by Single-Strand Annealing (SSA). DNA binding assays show that Saw1 binds a variety of branched DNA substrates that contain one or two single-strand flaps as well as a replication fork model substrate. This study is an important contribution to the field of DNA repair and recombination and should be of interest to a broad audience in that field.
However I do have quite a few experimental concerns and general questions that are raised below. The manuscript would also benefit from a thorough editing as there are many typos, badly referenced figures etc... The clarity of the figures could also often be improved with the addition of more information provided within the figure itself. Fig 1C/Fig1D In absence of Slx4, the recruitment of Rad1 is faster (compare 1h time points) on the proximal side of the break compared to the rad1nuc strain. Is this reproducible? There seems to be no error bar for the 1h slx4-delta time point. Surprisingly, on the distal side of the break the rate of recruitment of Rad1 does not seem to be impacted at 1 and 2h in absence of Slx4 but apparently it stops increasing at 3h. Interestingly the recruitment of Msh2 seems to be faster than that of Rad1 and this fast recruitment seems to rely on Slx4 but not Saw1 since the recruitment of Msh2 is slowed down in absence of Slx4 but not Saw1 (Fig 2) . These results would suggest that Slx4 might slow down the recruitment of Rad1 on the proximal side of the break while promoting the recruitment of Msh2. The authors need to comment on those differences. What is the rational for using the DNA crosslinker HN2 to support the idea that Saw1 is involved in the recruitment of Rad1-Rad10 to 3'tails during SSA? The same applies to the alkylating agent MMS used in Fig S10. Are we looking at Saw1 mediated recruitment of Rad1-Rad10 during SSA or is Saw1 involved in recruitment of Rad1-Rad10 to DNA in other HR mediated DNA damage repair pathways?
EXPERIMENTAL CONCERNS AND GENERAL QUESTIONS
In Fig 5 the microscopy data are rather scarce. Images of non-treated cells need to be shown. What are the Rad1 foci? Are they induced by HN2 or are they also seen in a non-treated cell? The authors need to show what they consider to be colocalized Rad1/Rad52 foci as some foci seem to be juxtaposed rather than colocalized.
Fig 6 and 7
The stoichiometry of the complex in the D to K fractions changes significantly. Those fractions with the most Rad10 have the least Saw1 and vice-versa except for fractions G and H, which seem to have high amounts of both Rad10 and Saw1 compared to the other fractions. Surprisingly, while fraction H has the highest activity of all, fraction G has one of the lowest. Why is this?
Fig 7
The authors indicate with an asterisk what they claim to be a non-specific cleavage product. How did they confirm that this product was non-specific? Do they get it with a nuclease dead Rad1-Rad10 prep for example?
General comments:
In figure 3 Saw1 binds efficiently to a Fork structure that has no single-stranded ends. I believe that a Fork structure is poorly cleaved by Rad1-Rad10 compared to a splayed arm structure. However, considering that Saw1 efficiently binds a fork structure, it would be worthwhile looking at whether Saw1 may increase the ability of Rad1-Rad10 to process such a substrate. Related to the previous point, it is quite surprising in fact that Saw1 binds a Fork structure considering that the longer the single-stranded flap on a 3'Flap structure the better it is bound by Saw1. Could this suggest that rather than favoring the long single-stranded flap structure, it favors structures with forced angles imposed on of the strands of DNA.
Can Saw1 promote recruitment/stabilization of Rad1-Rad10 on a structure containing a doublestrand/single-strand junction but without single-stranded ends such as a stem-loop or an NER bubble structure?
TYPOS, UNCLEAR OR MISSING LEGENDS ETC... "We therefore investigated whether Saw1's affinity to 3' flap DNA as a function of the length of the 3' tails ( Fig. 3C )" Did the authors mean to write "whether Saw1's affinity to 3' flap DNA increases as a function of...?
DNA substrates for EMSA. "All DNA substrates for EMSA were end-labeled by -32P-ATP and purified by gel electrophoresis. Sequences for each oligonucleotide will be provided upon request." Sequences of the oligonucleotides should be provided in a table.
Fig S7 and S8 figure legends should be inverted. The data in S8 are those commented in the text as being in S7 etc.. There also are a few mixes and confusions in the result section pages 9 and 10. Overall, it is essential that the data in Fig S7 and S8 are much more rigorously commented. Please find attached our revised manuscript entitled "Role of Saw1 in Rad1/Rad10 Complex Assembly at Recombination Intermediates in Budding Yeast" (EMBOJ-2012-82508) . The reviewer's comments were very helpful and allowed us to improve our paper significantly. Multiple experiments were performed to address the reviewers' questions and concerns. The results of these experiments were included in the main manuscript or in the supplemental data. Below is our pointby-point response to each reviewer's comments. We believe that we have made all the changes requested by the reviewers.
Referee #1
1. Fig. 5 . Some of the data in Figure 5A The experiments shown in Fig. 5 used 6XHis-Rad1, Rad10 and 6XHis-Saw1 or 6XHis-saw1 mutant proteins, co-expressed and purified in E.coli using cobalt resin column chromatography. AnThe increasing amount of purified Rad1/Rad10/Saw1 (and saw1 mutants) was then incubated with 32 P labeled 3' flap DNA substrates and the samples were subjected to polyacrylamide gel electrophoresis followed by autoradiography. Therefore, the labeling shown in the original Fig. 5 was inaccurate and we revised the manuscript to clearly indicate that not just Saw1 but also the increasing amount of Rad1/Rad10 were added in the lane 5-8, 9-12, and 13-16 of Fig. 5 . Since we confirmed the amount of Rad1/Rad10 and Saw1 (or saw1 mutants) used in EMSA were near equivalent across different Saw1 derivative preparations (see Fig. S10 ), we are confident that the outcome of our EMSA was not dictated by the subtle difference in the amount of Saw1 or Rad1/Rad10 used in EMSA and between sample preparations. Nevertheless, to avoid such unlikely possibilities further, we performed yet another EMSA with the fixed amount of Rad1/Rad10 and the increasing amount of Saw1 or saw1 mutant as we described in our original manuscript (Fig. S11) . The results were consistent with our conclusion that only wild type Saw1 can induce a higher order nucleoprotein complex when incubated with Rad1/Rad10 and 3' flap DNA substrates. Taken together, our results strongly suggest that Saw1 targets Rad1/Rad10 to 3' flap recombination intermediates.
Fig. S9. Saw1 appears to be present in significant excess over Rad1/10, even though if was purified through affinity with Rad1/10. Do the authors have an explanation for that -could SAW1 be present as a multimer?
We apologize for the confusion with this figure. The purification is of His-tagged Rad1, untagged Rad10 and His-tagged Saw1. This is the purification used to isolate complexes used for the gel mobility shift assays in Figure 5 . Therefore the purification of His-Saw1 is not through Saw1's affinity to Rad1, in this case. This approach was taken in order to purify mutant forms of Saw1 for use in the gel mobility shift assays. Later figures (Fig. 6 and 7) demonstrate purification of the complex in which Saw1 is untagged.
Throughout: indicate amounts of protein and substrates used as concentrations rather than ng amounts.
We have modified the manuscript to indicate the amounts of the proteins and DNA substrates used in biochemical studies as concentrations. with the exception of the amount of Rad1/Rad10/Saw1 used in Fig. 5A . To respond to the reviewer's suggestion, we measured the survival frequency of saw1-deleted cells following the nitrogen mustard treatment. We found that saw1 deletion did not sensitize cells to nitrogen mustard treatment. The results may suggest that Saw1 may be dispensable for the repair of nitrogen mustard induced DNA lesions. The results thus raised a question about the nature of Venus-Rad1 nuclear foci and their co-localization with Rad52-CFP in Saw1 dependent manner after nitrogen mustard exposure. To reconcile these conflicting observations, we are currently investigating the possibility if other factors such as Mus81 can compensate for the loss of SAW1 by channeling ICL lesions to other repair pathways. However, such studies require extensive analysis of gene mutant combination and we hope to report the outcomes of this investigation as a separate paper. We therefore constructed yeast strains expressing Venus-Rad1 with TetR-mRFP/TetO arrays flanking the direct repeat sequence to mark the site of SSA intermediates. We then monitored the formation of Venus-Rad1 foci upon HO expression and their co-localization with TetR-mRFP foci under a fluorescence microscope. The results show that HO expression induces the formation of Venus-Rad1 foci and their co-localization with TetR-mRFP foci. The number of Venus-Rad1 and their co-localization with TetR-mRFP depends on functional Saw1. The results support our model that Saw1 recruits Rad1 to 3' flap recombination intermediate. (Andersen et al; Fekari et al; Munoz et al; Svensden et al and Crossan et al Nat. Genet, 2011; Kim et al Nat Genet. 2011; Stoepker et al, Nat Genet 2011) should be cited here. We have cited these references in the revised manuscript.
p4. 5th line: The paper by Motycka, 2004 shows a physical interaction between Rad52 and ERCC1-XPF, but not that this interaction is essential for targeting ERCC1-XPF to 3' non-homologous tails.
Either correct sentence or provide another reference that directly shows a role for Rad52 in targeting ERCC1-XPF to those sites. We have modified the sentence to "Rad52 directly interacts with ERCC1 and this interaction stimulates XPF endonuclease activity in processing 3' non-homologous tailed substrates" in accordance to the Reviewer's suggestion.
p6./ Fig. S3 . Please also show recruitment data for WT-Rad1 in Figure S3 so that the reader can appreciate the effect of the nuclease-deficient mutant. We have revised the manuscript to show the lack of recruitment of nuclease-competent, wild type Rad1 at 3' tailed intermediates ( Figure S3A ).
Fig. 2. Labeling of the panel would make this figure easier to read.
We have indicated the identity of the target molecule for ChIP assay and the position of the PCR analysis in the panels to make Figure 2 easier to read.
Referee #2
Minor points: 1. rad1 should be in italics throughout; in places it's not italicized e.g. p6
We have revised the manuscript as the reviewer suggested.
In Figs 2C, D there's less Rad1-Rad10 recruited at the 3hr time points -is this difference reproducible and is it significant? Is the effect more pronounced at later time points?
The reduction of Saw1 recruitment in slx4 mutant in Fig. 2C and D is moderate and the error bars are overlapping to each other between the values of wild type and slx4 mutants. We therefore consider that the differences are likely due to experimental variations and did not emphasize nor speculate further on the role of Slx4 in Rad1/Rad10 recruitment.
In the discussion (p15) the authors state that Slx4 is a nuclease; it is not, it has no nuclease motifs. The data in support of Slx4 being a nuclease are weak, and the activity observed is almost certainly due to a contaminating nuclease.
We have modified the paragraph to " Slx4 is proposed to be a nuclease".
Rad1-Rad10 interacts with SlxHowever, the authors showed previously that recruitment of Slx4 to 3' flaps during SSA does not require Saw1, even though in their current study they show that Rad1 recruitment requires Saw1. The authors must attempt to reconcile these data and provide possible explanations.
Based on our results, we propose that the physical interaction between Rad1-Rad10 and Slx4 likely occurs after recruitment of Rad1/Rad10 to the 3' tailed substrate. At present, we do not know the precise role of physical interaction between Rad1-Rad10 and Slx4. We speculate that it may be important for turning over of Rad1-Rad10 following enzyme cleavage or for coordinating the action of Rad1-Rad10 with checkpoint response during 3' flap cleavage. Further experiments are needed to resolve this question.
Referee #3

The manuscript would also benefit from a thorough editing as there are many typos, badly referenced figures etc... The clarity of the figures could also often be improved with the addition of more information provided within the figure itself.
The manuscript was carefully edited to eliminate any typographical errors and inaccurate citation of the figures and tables. We apologize to the reviewers for these mistakes.
Fig 1C/Fig1D In absence of Slx4, the recruitment of Rad1 is faster (compare 1h time points) on the proximal side of the break compared to the rad1nuc strain. Is this reproducible? There seems to be no error bar for the 1h slx4-delta time point. Surprisingly, on the distal side of the break the rate of recruitment of Rad1 does not seem to be impacted at 1 and 2h in absence of Slx4 but apparently it stops increasing at 3h. Interestingly the recruitment of Msh2 seems to be faster than that of Rad1 and this fast recruitment seems to rely on Slx4 but not Saw1 since the recruitment of Msh2 is slowed down in absence of Slx4 but not Saw1 (Fig 2). These results would suggest that Slx4 might slow down the recruitment of Rad1 on the proximal side of the break while promoting the recruitment of Msh2. The authors need to comment on those differences.
The faster recruitment of Rad1 in the absence of SLX4 at 1 h post HO expression is reproducible in our hands and the error bars was included in the original manuscript albeit it is too small to detect easily. We appreciate the reviewer's interest in these differences and agree that they are intriguing. We have hesitated to draw too many conclusions based on the somewhat qualitative ChIP assay. We have added a brief additional discussion of these possibilities in the revision (page 7). Fig 3C. The size of the single strand DNA flaps used in Fig. 3B is 30 nucleotides. We describe this in the figure legend.
Fig 3: The authors need to mention what is the size of the single-strand flaps in the various structures used in Fig3B so that we can compare the results with those in
Why are the shifts seen with 2.5nM Saw1 in Fig 3B on the splayed arm, 3 The amount of Saw1 used in Fig. 3B of the original manuscript was described inaccurately. We added 200 nM (not 2.5 nM) Saw1 to the reaction mixture. We have revised the manuscript to fix the error and describe the accurate amount of Saw1 used in the experiments. We apologize to the reviewer for this mistake. In the original manuscript, we intended to show the recruitment of Rad1/Rad10 at 3' tailed HR intermediates and its dependence on Saw1 proteins. However, we are aware that HN 2 and MMS likely generate wide ranges of DNA lesions and the nature of DNA lesions Rad1-Rad10 associates is difficult to define. Facing with this limitation, we constructed yeast strains expressing VenusRad1 fusion protein and carrying 112x tetO/TetR-mRFP arrays adjacent to a HO break flanked by SSA substrates. The arrangements allow us to directly monitor recruitment of Rad1 to SSA substrate and its dependence on Saw1. We found that expression of HO increases the nuclear focus formation by Venus-Rad1 and its co-localization with TetR-mRFP that marks the site of SSA repair (Fig. 5C) . Our results fully support the model that Saw1 plays a key role in the recruitment of Rad1/Rad10 to the SSA intermediates. We thus replaced the MMS and HN 2 results with those of HO induced SSA repair in the revision.
In Fig 5 the microscopy data are rather scarce. Images of non-treated cells need to be shown. What are the Rad1 foci? Are they induced by HN2 or are they also seen in a non-treated cell? The authors need to show what they consider to be colocalized Rad1/Rad52 foci as some foci seem to be juxtaposed rather than colocalized.
Even without drug treatment, many cells exhibit spontaneous Rad1 foci that may represent the site of NER and/or spontaneous HR events. However, these spontaneous foci rarely co-localize with spontaneous Rad52 foci. Upon HN 2 or MMS treatment, the number of Rad1 foci is increased and more importantly the percentage of cells with Rad1 foci colocalizing with Rad52 foci is elevated. Furthermore, we have now demonstrated that Venus-Rad1 forms nuclear foci upon HO expression and co-localizes with TetR-mRFP marking the site of SSA repair. In the revision, we included a typical image of HO induced and un-induced cells and the position of Venus-Rad1 and TetR-mRFP to demonstrate the recruitment of Rad1 to SSA substrates to alleviate the reviewer's concern. Fig 6 and 7 
The stoichiometry of the complex in the D to K fractions changes significantly. Those fractions with the most Rad10 have the least Saw1 and vice-versa except for fractions G and H, which seem to have high amounts of both Rad10 and Saw1 compared to the other fractions.
We appreciate the reviewer's observation and were also intrigued by this profile. We have repeated the complex purification several times since the original submission and we have consistently observed a purification profile more consistent with co-purification of all three proteins. We do see variations in relative stoichiometry, indicating that we are purifying multiple complexes, rather than a single population. This is consistent with observing the three proteins co-purifying over several fractions of decreasing molecular weight. We have replaced the original figure with one that is more representative of what we have seen with several protein preparations ( Figure 6C ). In this, the elution profile of Rad10 is shifted somewhat.
Surprisingly, while fraction H has the highest activity of all, fraction G has one of the lowest. Why is this?
In the newer complex purifications that we have performed, where our fraction sizes were slightly altered relative to that shown in our original submission, we observed a narrower peak of endonuclease activity and the fractions that correspond to H did not have elevated endonuclease activity. We have modified Figures 7A and B (now Figures 7A and C) to reflect these differences. Figure 7D includes activity profiles for several additional preps. We also performed the endonuclease assays at a lower NaCl concentration (50mM) at which we observe more robust cleavage activity. We similarly observed a stimulation of endonuclease activity of fractions comprising Rad1/Rad10/Saw1 relative to Rad1/Rad10 alone. These data are now included in Figure  7B .
We also performed pull-down assays with the fractions with elevated activity, to determine whether an additional protein was co-purifying with Rad1/Rad10/Saw1 that might alter catalytic activity. In these experiments we did not observe any protein that was not present when we performed the same experiment using purified HRad1/Rad10 alone (data not shown).
Fig 7 The authors indicate with an asterisk what they claim to be a non-specific cleavage product. How did they confirm that this product was non-specific? Do they get it with a nuclease dead Rad1-Rad10 prep for example?
We appreciate the reviewer's comment and we have added a sentence to the text clarifying that this band is often present with the endonuclease dead mutant of Rad1 and in the absence of Rad1-Rad10 and we refer to it as a likely non-specific activity.
In figure 3 Saw1 binds efficiently to a Fork structure that has no single-stranded ends. I believe that a Fork structure is poorly cleaved by Rad1-Rad10 compared to a splayed arm structure. However, considering that Saw1 efficiently binds a fork structure, it would be worthwhile looking at whether Saw1 may increase the ability of Rad1-Rad10 to process such a substrate. The fact that Saw1 binds well to the fork structure is intriguing and suggests that Saw1 recognizes both ssDNA and structured DNA (see below). In response to this comment, we tested the ability of Rad1/Rad10 and Rad1/Rad10/Saw1 fractions to cleave a fork substrate. We observed no cleavage of this substrate by Rad1/Rad10, with or without Saw present. These data are now included in Figure S13D .
Related to the previous point, it is quite surprising in fact that Saw1 binds a Fork structure considering that the longer the single-stranded flap on a 3'Flap structure the better it is bound by Saw1. Could this suggest that rather than favoring the long single-stranded flap structure, it favors structures with forced angles imposed on of the strands of DNA. Can Saw1 promote recruitment/stabilization of Rad1-Rad10 on a structure containing a doublestrand/single-strand junction but without single-stranded ends such as a stem-loop or an NER bubble structure? In response to the reviewer's suggestion, we assessed the binding of Saw1 to stem-loop DNA with two different sizes of loop (10 and 20 nucleotides) and DNA substrates with 7 or 14 bp bubble (Fig.  S6) . We found that Saw1 did not bind to stem-loop DNA regardless of the sizes of loop nor to DNA with 7 bp bubble. However, Saw1 binds efficiently to DNA containing 14 bp bubble. We also performed a competition experiment adding different amount of cold Y DNA or 14 bp bubble containing DNA to the reaction mixture with 32P labeled 14 bp bubble DNA substrate and Saw1 protein using EMSA. We found that Saw1 binds to both Y DNA and bubble DNA equally well and either DNA can compete with the 14 bp bubble DNA in EMSA experiments. The results suggest that Saw1 alone may not be sufficiently specific to target Rad1-Rad10 to 3' tailed DNA in SSA or subset of recombination. We propose that the ability of Saw1 to bind both structured DNA and Rad52 may contribute to the recruitment of Rad1-Rad10 to recombination substrates. We are currently testing this idea.
Missing legend on Fig S10A
We have added a figure legend for Fig. S10A in the revised manuscript.
Fig S5A doesn't show binding of Saw1 to Rad1 and Msh2?
We have modified the manuscript to ""Purified Saw1 interacts with Rad1 and Rad52, indicating that it is functional (Fig. S5A) (Fig. S5B) " Fig S5B shows only anti-6His . No data with anti-Saw1. So latter needs to be mentioned as data not shown.
We have now included the super-shift experiment results with anti-Saw1 antibody in Fig. S5B .
"We therefore investigated whether Saw1's affinity to 3' flap DNA as a function of the length of the 3' tails (Fig. 3C) There also are a few mixes and confusions in the result section pages 9 and 10. We have modified the manuscript to avoid any mixes and confusions. Fig S7 and S8 are much more rigorously commented. We have added the sentence to discuss the data in Fig. S9 . Thank you for submitting your revised manuscript for our consideration. Two of the original referees have now reviewed it once more, and I am pleased to inform you that both of them consider the manuscript significantly improved and now suitable for publication in The EMBO Journal. Only referee 1 still makes some specific points that should be altered before publicaiton. We shall therefore in principle be happy to accept the study, pending adequate additional modification and clarification of a number of remaining editorial issues, as follows:
Overall, it is essential that the data in
-Referee 1 has some minor comments regarding the presentation/writing that I would kindly ask you to take into account in a final round of text and data modification.
-Regarding statistical analysis, I noticed that several diagrams contain mean values and error bar calculations for only two replicates. Since standard deviations for N=2 are not statistically meaningful, we would require either an increase in the number of experimental replicates (to N{greater than or equal to}3) to allow for proper statistical analysis (e.g. SEM calculation), or alternatively re-plotting of these data, to show vertically arranged individual data points together with a line denoting the mean, instead of a simple column plot. Please refer also our Guide to Authors for further reference and guidance on these issues.
-A number of blot/gel figure panels (both in the main manuscript and in the supplement) remain of insufficient quality for proper assessment and publication. The three main issues are (a) pixelated appearance due to insufficient resolution, (b) over-adjusted contrast/brightness settings that lead to loss of background signals, and (c) assembly of panels from separate individuals lanes, often without clear indication.
To verify that all these panels adequately represent the original data, we will require the source data for all the various electrophoretic gel and blot panels to be included with the final version. We would ask for a single PDF/JPG/GIF file per figure comprising the original, uncropped and unprocessed scans of all gel/blot panels used in the respective figures. These should be labelled with the appropriate figure/panel number, and should have molecular weight markers; further annotation would clearly be useful but is not essential. A ZIP archive containing these individual files can be uploaded upon resubmission (selecting " Figure Source Data" as object type) and would be published online with the article as a supplementary "Source Data" file. Furthermore, all main and supplemental figures should be modified as appropriate to a sufficiently high image quality (resolution, background visibility etc), and to include clearly visible separation lines wherever originally non-adjacent lanes have been put together. This should be further clearly explained and justified in the respective figure legends (e.g. 'removal of irrelevant lanes but all from the same gel/exposure' etc), with a reference to the unmodified source data file that will be available as an additional online supplement.
-Finally, regarding files and format for production and publication: we will require (a) the main manuscript text, in word processor text format, (b) one individual figure file for each of the main figures, (c) one single 'Supplementary Information' PDF of sufficiently high image quality and sufficiently small file size (i.e. less than 10 Mb) to facilitate download by our readers, and (d) the above-mentioned ZIP archive containing the blot source data.
I am therefore returning the manuscript to you once more to allow you to add the required information and make the remaining modifications in a final round of minor revision; hoping you will be able to upload and re-submit a final version as soon as possible. Should you have any questions in this regard, please do not hesitate to contact me directly.
_____ REFEREE REPORTS:
I find the revised version of this manuscript much improved and think the manuscript is now suitable for publication in EMBO J. pending some the following minor revisions: - Figure 5 : Please indicate amounts of protein in [nM] rather than ug/ml. Since the complexes have different molecular weights a comparison of concentrations is more meaningful than a comparison of ug amounts.
-p.16. In response to the review the authors changes a statement to "Slx4 is proposed to be a nuclease". I think this statement is wrong as it is now clear that the nuclease active is in Slx1, or then XPF and Mus81, other proteins associated with Slx4. Slx4 has no known nuclease activity and I do no think anybody in the field thinks it does anymore. Please adjust statement accordingly. Please find attached our revised manuscript entitled "Role of Saw1 in Rad1/Rad10 Complex Assembly at Recombination Intermediates in Budding Yeast" (EMBOJ-2012-82508R). We revised the manuscript according to the reviewer's suggestions, including the source data for all the electrophoretic gel and blot panels described in the manuscript. Below is our point-by-point response to the reviewer's and your editorial concerns. We believe that we have made all the changes requested by the reviewers.
Response to Reviewer #1's comments We have modified the sentence from "Slx4 itself is a DNA binding protein and proposed to be a nuclease" to "Slx4 itself is a DNA binding protein and forms a heterodimeric, structure-specific endonuclease complex with Slx1."
Response to Editorial considerations 1. We have modified Fig. 5D , 7C and 7D to show vertically arranged individual data points and a line denoting the mean value ( Fig. 7C and 7D ).
2.
We have also uploaded a Zip archive containing source files that contain original, uncropped and unprocessed scans of all gel/blot panels used in the respective figures and are labeled/arranged to indicate the figure and panel numbers listed in the manuscript or supplementary information. We have also modified Figure S5A , S8A, and S10 to a higher resolution and have added the line in Fig. 3B, 3C , 5B to indicate that non-adjacent lanes have been put together. We have also added molecular weight in Fig. S8B . The assembly of panels from separate individuals lanes were explained in the figure legend as suggested. We have also indicated the availability of unmodified source data file as an additional online supplement.
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Thank you for submitting the final version of your manuscript with the last minor changes, which I have now had a chance to evaluate. I am very pleased to inform you that we have decided to accept your study for publication in The EMBO Journal.
Thank you again for your contribution to our journal and congratulations on a successful publication. Please consider us again in the future for your most exciting work.
